Comparison of intravenous and intermittent furosemide injection on pulmonary status and heart failure of newborns - Trial IRCT20210317050737N1
Access comprehensive clinical trial information for IRCT20210317050737N1 through Pure Global AI's free database. This Phase 2 trial is sponsored by Kerman University of Medical Sciences and is currently Suspended. The study focuses on Heart failure.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
IRCT20210317050737N1
Phase 2
Suspended
Trial Details
Iranian Registry Of Clinical Trial • IRCT20210317050737N1
Comparison of intravenous and intermittent furosemide injection on pulmonary status and heart failure of newborns
Comparison of the effects of continuous versus bolus intermittent Furosemide infusion on the pulmonary status and, hemodynamic responses in neonates with congestive heart failure
Study Focus
Interventional
Sponsor & Location
Kerman University of Medical Sciences
Iran
Timeline & Enrollment
Phase 2
Jan 21, 2023
N/A
ICD-10 Classifications
Heart failure
Heart failure, unspecified
Congestive heart failure
Hypertensive heart disease with (congestive) heart failure
Left ventricular failure
Data Source
Iranian Registry Of Clinical Trial
IRCT20210317050737N1
Non-Device Trial